The global thymine market is expected to grow at a CAGR of 3.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of the market can be attributed to the increasing demand for pharmaceutical intermediates and bioengineering applications in various industries such as food & beverage, cosmetics, and healthcare. Thymine (97%) segment is expected to account for a significant share of the global thymine market during the forecast period owing to its high demand in pharmaceutical intermediates application. Thymine (99%) segment is also expected to witness significant growth due to its high demand in bioengineering application which includes DNA sequencing and gene editing among others. North America accounted for a major share of the global thymine market owing to its presence in developed economies such as US, Canada, and Mexico among others which are witnessing an increase in research activities related with biotechnology and pharmaceuticals sectors that are driving up demand for thymine products across these regions.
Some Of The Growth Factors Of This Market:
- Thymine is a nucleobase that is found in DNA and RNA.
- Thymine is an essential component of DNA, which makes up the genetic code for all living organisms on Earth.
- Thymine can be used to make thyminesulfonic acid, which has many industrial applications such as in the production of polymers and dyes, as well as in the manufacture of pharmaceuticals and agricultural chemicals.
Industry Growth Insights published a new data on “Thymine (CAS 65-71-4) Market”. The research report is titled “Thymine (CAS 65-71-4) Market research by Types (Thymine (97%), Thymine (99%), Other), By Applications (Pharmaceutical Intermediates, Bioengineering, Other), By Players/Companies Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thymine (CAS 65-71-4) Market Research Report
By Type
Thymine (97%), Thymine (99%), Other
By Application
Pharmaceutical Intermediates, Bioengineering, Other
By Companies
Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Thymine (CAS 65-71-4) Market Report Segments:
The global Thymine (CAS 65-71-4) market is segmented on the basis of:
Types
Thymine (97%), Thymine (99%), Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Intermediates, Bioengineering, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sintofarm S.P.A.
- Yulchon Pharmaceutical
- 3B Pharmachem
- Sigma-Aldrich
- Morre-Tec Industries
- Cambridge Isotope
- George Uhe Company
- Degussa Fine Chemicals
- Taiyuan RHF
- Sarepta Therapeutics
- Zhangjiagang Aihua Chemical
- Wuhan Yuancheng Gongchuang Technology
Highlights of The Thymine (CAS 65-71-4) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Thymine (97%)
- Thymine (99%)
- Other
- By Application:
- Pharmaceutical Intermediates
- Bioengineering
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thymine (CAS 65-71-4) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thymine is a chemical element with the symbol T and atomic number 66. Thymine is a radioactive element that occurs naturally in the environment. It is also produced by the irradiation of other elements. Thymine is used in nuclear reactors to create energy.
Some of the major companies in the thymine (cas 65-71-4) market are Sintofarm S.P.A., Yulchon Pharmaceutical, 3B Pharmachem, Sigma-Aldrich, Morre-Tec Industries, Cambridge Isotope, George Uhe Company, Degussa Fine Chemicals, Taiyuan RHF, Sarepta Therapeutics, Zhangjiagang Aihua Chemical, Wuhan Yuancheng Gongchuang Technology.
The thymine (cas 65-71-4) market is expected to grow at a compound annual growth rate of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Thymine (CAS 65-71-4) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Thymine (CAS 65-71-4) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Thymine (CAS 65-71-4) Market - Supply Chain
4.5. Global Thymine (CAS 65-71-4) Market Forecast
4.5.1. Thymine (CAS 65-71-4) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Thymine (CAS 65-71-4) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Thymine (CAS 65-71-4) Market Absolute $ Opportunity
5. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
5.3.1. Thymine (97%)
5.3.2. Thymine (99%)
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Intermediates
6.3.2. Bioengineering
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Thymine (CAS 65-71-4) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Thymine (CAS 65-71-4) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026
9. North America Thymine (CAS 65-71-4) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Intermediates
9.4.2. Bioengineering
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
9.7.1. Thymine (97%)
9.7.2. Thymine (99%)
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026
10. Latin America Thymine (CAS 65-71-4) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Intermediates
10.4.2. Bioengineering
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
10.7.1. Thymine (97%)
10.7.2. Thymine (99%)
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Thymine (CAS 65-71-4) Demand Share Forecast, 2019-2026
11. Europe Thymine (CAS 65-71-4) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Intermediates
11.4.2. Bioengineering
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
11.7.1. Thymine (97%)
11.7.2. Thymine (99%)
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Thymine (CAS 65-71-4) Demand Share, 2019-2026
12. Asia Pacific Thymine (CAS 65-71-4) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Intermediates
12.4.2. Bioengineering
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
12.7.1. Thymine (97%)
12.7.2. Thymine (99%)
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Thymine (CAS 65-71-4) Demand Share, 2019-2026
13. Middle East & Africa Thymine (CAS 65-71-4) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Intermediates
13.4.2. Bioengineering
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Thymine (CAS 65-71-4) Market Size and Volume Forecast by Type
13.7.1. Thymine (97%)
13.7.2. Thymine (99%)
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Thymine (CAS 65-71-4) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Thymine (CAS 65-71-4) Market: Market Share Analysis
14.2. Thymine (CAS 65-71-4) Distributors and Customers
14.3. Thymine (CAS 65-71-4) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sintofarm S.P.A.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Yulchon Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. 3B Pharmachem
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sigma-Aldrich
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Morre-Tec Industries
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cambridge Isotope
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. George Uhe Company
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Degussa Fine Chemicals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Taiyuan RHF
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sarepta Therapeutics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zhangjiagang Aihua Chemical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Wuhan Yuancheng Gongchuang Technology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook